These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23419580)

  • 1. MRI findings of adult maple syrup urine disease exacerbation.
    Rawal S; Faghfoury H; Krings T
    Can J Neurol Sci; 2013 Mar; 40(2):259-62. PubMed ID: 23419580
    [No Abstract]   [Full Text] [Related]  

  • 2. Pattern of restricted diffusion seen on magnetic resonance imaging in maple syrup urine disease.
    Kar J; Nguyen FN; Moody SB
    Pediatr Neurol; 2013 Dec; 49(6):505-6. PubMed ID: 24080272
    [No Abstract]   [Full Text] [Related]  

  • 3. Teaching NeuroImages: MRI in maple syrup urine disease.
    Bindu PS; Kovoor JM; Christopher R
    Neurology; 2010 Jan; 74(3):e12. PubMed ID: 20083792
    [No Abstract]   [Full Text] [Related]  

  • 4. Maple syrup urine disease: diffusion-weighted and diffusion-tensor magnetic resonance imaging findings.
    Parmar H; Sitoh YY; Ho L
    J Comput Assist Tomogr; 2004; 28(1):93-7. PubMed ID: 14716239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maple syrup urine disease: diffusion MRI, and proton MR spectroscopy findings.
    Sener RN
    Comput Med Imaging Graph; 2007 Mar; 31(2):106-10. PubMed ID: 17207604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion-weighted magnetic resonance imaging in a case of severe classic maple syrup urine disease.
    Xia W; Yang W
    J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):805-8. PubMed ID: 25879313
    [No Abstract]   [Full Text] [Related]  

  • 7. Age dependence of diffusion-weighted magnetic resonance imaging findings in maple syrup urine disease encephalopathy.
    Sakai M; Inoue Y; Oba H; Ishiguro A; Sekiguchi K; Tsukune Y; Mitomo M; Nakamura H
    J Comput Assist Tomogr; 2005; 29(4):524-7. PubMed ID: 16012312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maple syrup urine disease encephalopathy: a follow-up study in the acute stage using diffusion-weighted MRI.
    Ha JS; Kim TK; Eun BL; Lee HS; Lee KY; Seol HY; Cha SH
    Pediatr Radiol; 2004 Feb; 34(2):163-6. PubMed ID: 14504844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT and MRI in maple syrup urine disease.
    Uziel G; Savoiardo M; Nardocci N
    Neurology; 1988 Mar; 38(3):486-8. PubMed ID: 3347354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion-weighted MRI of maple syrup urine disease encephalopathy.
    Cavalleri F; Berardi A; Burlina AB; Ferrari F; Mavilla L
    Neuroradiology; 2002 Jun; 44(6):499-502. PubMed ID: 12070724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neonatal presentation of maple syrup urine disease].
    Cardoen L; Schiff M; Lambron J; Rega A; Virlouvet AL; Biran V; Eleni Dit Trolli S; Elmaleh-Bergès M; Alison M
    Arch Pediatr; 2016 Dec; 23(12):1291-1294. PubMed ID: 27816400
    [No Abstract]   [Full Text] [Related]  

  • 12. [Maple syrup urine disease].
    Incesu L; Tasdemir HA; Yazicioglu AK; Belet U; Danaci M
    Radiol Med; 2001 Sep; 102(3):194-6. PubMed ID: 11677467
    [No Abstract]   [Full Text] [Related]  

  • 13. Maple syrup urine disease: metabolic decompensation monitored by proton magnetic resonance imaging and spectroscopy.
    Felber SR; Sperl W; Chemelli A; Murr C; Wendel U
    Ann Neurol; 1993 Apr; 33(4):396-401. PubMed ID: 8489211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Water apparent diffusion coefficient and T2 changes in the acute stage of maple syrup urine disease: evidence of intramyelinic and vasogenic-interstitial edema.
    Righini A; Ramenghi LA; Parini R; Triulzi F; Mosca F
    J Neuroimaging; 2003 Apr; 13(2):162-5. PubMed ID: 12722501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging in neonatal maple syrup urine disease.
    Jain P; Sharma S; Sankhyan N; Gupta N; Kabra M; Gulati S
    Indian J Pediatr; 2013 Jan; 80(1):87-8. PubMed ID: 22865353
    [No Abstract]   [Full Text] [Related]  

  • 16. MRI in acute intermittent maple syrup urine disease.
    Di Rocco M; Biancheri R; Rossi A; Allegri AE; Vecchi V; Tortori-Donati P
    Neurology; 2004 Sep; 63(6):1078. PubMed ID: 15452301
    [No Abstract]   [Full Text] [Related]  

  • 17. [A mild variant case of maple syrup urine disease].
    Ishikawa A; Okayasu T; Miyasaka K; Fukushima N; Takase A; Wagatsuma Y
    No To Hattatsu; 1991 Jan; 23(1):71-4. PubMed ID: 1994996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal case of classic maple syrup urine disease: usefulness of (1) H-MRS in early diagnosis.
    Sato T; Muroya K; Hanakawa J; Asakura Y; Aida N; Tomiyasu M; Tajima G; Hasegawa T; Adachi M
    Pediatr Int; 2014 Feb; 56(1):112-5. PubMed ID: 24548198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-[fluorine-18] fluoro-2-deoxy-D-glucose PET scan of the brain in maple syrup urine disease.
    al-Essa M; al-Hussein K; Ozand PT
    Clin Nucl Med; 1999 Aug; 24(8):612-3. PubMed ID: 10439189
    [No Abstract]   [Full Text] [Related]  

  • 20. MR diffusion imaging and MR spectroscopy of maple syrup urine disease during acute metabolic decompensation.
    Jan W; Zimmerman RA; Wang ZJ; Berry GT; Kaplan PB; Kaye EM
    Neuroradiology; 2003 Jun; 45(6):393-9. PubMed ID: 12736767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.